Combined use of low-intensity pulsed ultrasound and rhBMP-2 to enhance bone formation in a rat model of critical size defect.
Combined use of low-intensity pulsed ultrasound and rhBMP-2 to enhance bone formation in a rat model of critical size defect.
复制标题
DOI:
10.1097/bot.0000000000000067
复制
发表时间:
2014-10
影响因子:
2.3
通讯作者:
Virdi AS
中科院分区:
文献类型:
--
作者:
Angle SR;Sena K;Sumner DR;Virkus WW;Virdi AS
Bone repair is regulated by biological factors and the local mechanical environment. We hypothesize that the combined use of low intensity pulsed ultrasound (LIPUS) and recombinant human bone morphogenetic protein-2 (rhBMP-2) will synergistically or additively enhance bone regeneration in a model simulating the more difficult scenarios in orthopedic traumatology. Femoral defects in rats were replaced with absorbable collagen sponges carrying rhBMP-2 (0, 1.2, 6 or 12μg; n=30). Each group was divided equally to receive daily treatment of either LIPUS or sham stimulation. At 4 weeks new bone formation was assessed using quantitative (radiography and microcomputed tomography), qualitative (histology) and functional (biomechanical) endpoints. LIPUS with 1.2μg of rhBMP-2 significantly improved the radiographic healing as compared to its sham control starting as early as 2 weeks. Quantitatively, the use of LIPUS with 6μg of rhBMP-2 significantly increased the bone volume. However, using LIPUS with 12μg of rhBMP-2 indicated a reduction in callus size, without compromising the bone volume, which was also observable histologically, showing organized lamellar bone and repopulated marrow in the original defect region. Histologically, 1.2μg of rhBMP-2 alone showed the presence of uncalcified cartilage in the defect which was reduced with LIPUS treatment. Biomechanically, LIPUS treatment significantly increased the peak torsion and stiffness in the 6μg and 12μg rhBMP-2 group. LIPUS enhances rhBMP-2 induced bone formation at lower doses (1.2μg and 6μg) and callus maturation at 12μg dose delivered on ACS for bone repair in a rat critical-sized femoral segmental defect.